Global Medications for Canine Atopic Dermatitis Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Medications for Canine Atopic Dermatitis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Medications for Canine Atopic Dermatitis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medications for Canine Atopic Dermatitis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medications for Canine Atopic Dermatitis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medications for Canine Atopic Dermatitis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac and Enzo Life Sciences, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Medications for Canine Atopic Dermatitis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Medications for Canine Atopic Dermatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medications for Canine Atopic Dermatitis, with price, sales, revenue and global market share of Medications for Canine Atopic Dermatitis from 2018 to 2023.
Chapter 3, the Medications for Canine Atopic Dermatitis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medications for Canine Atopic Dermatitis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medications for Canine Atopic Dermatitis market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medications for Canine Atopic Dermatitis.
Chapter 14 and 15, to describe Medications for Canine Atopic Dermatitis sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Medications for Canine Atopic Dermatitis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medications for Canine Atopic Dermatitis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Medications for Canine Atopic Dermatitis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medications for Canine Atopic Dermatitis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medications for Canine Atopic Dermatitis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac and Enzo Life Sciences, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Medications for Canine Atopic Dermatitis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- External Use
- Injection
- Veterinary Hospital
- Veterinary Clinic
- GlenHaven
- DermaPet
- DVM Pharmaceuticals
- Virbac
- Enzo Life Sciences, Inc.
- Pfizer Animal Health
- Novartis Animal Health, Inc.
- Eli Lilly and Company
- Perrigo
- Merck & Company
- Zoetis Inc.
- Toray Industries, Inc
- Bayer Animal Health
- Putney, Inc.
- Dechra
- Elanco
- Kindred Biosciences
- Nippon Zenyaku Kogyo Co., Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Medications for Canine Atopic Dermatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medications for Canine Atopic Dermatitis, with price, sales, revenue and global market share of Medications for Canine Atopic Dermatitis from 2018 to 2023.
Chapter 3, the Medications for Canine Atopic Dermatitis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medications for Canine Atopic Dermatitis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medications for Canine Atopic Dermatitis market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medications for Canine Atopic Dermatitis.
Chapter 14 and 15, to describe Medications for Canine Atopic Dermatitis sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Medications for Canine Atopic Dermatitis
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medications for Canine Atopic Dermatitis Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 External Use
1.3.4 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Medications for Canine Atopic Dermatitis Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Veterinary Hospital
1.4.3 Veterinary Clinic
1.5 Global Medications for Canine Atopic Dermatitis Market Size & Forecast
1.5.1 Global Medications for Canine Atopic Dermatitis Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medications for Canine Atopic Dermatitis Sales Quantity (2018-2029)
1.5.3 Global Medications for Canine Atopic Dermatitis Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GlenHaven
2.1.1 GlenHaven Details
2.1.2 GlenHaven Major Business
2.1.3 GlenHaven Medications for Canine Atopic Dermatitis Product and Services
2.1.4 GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlenHaven Recent Developments/Updates
2.2 DermaPet
2.2.1 DermaPet Details
2.2.2 DermaPet Major Business
2.2.3 DermaPet Medications for Canine Atopic Dermatitis Product and Services
2.2.4 DermaPet Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 DermaPet Recent Developments/Updates
2.3 DVM Pharmaceuticals
2.3.1 DVM Pharmaceuticals Details
2.3.2 DVM Pharmaceuticals Major Business
2.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product and Services
2.3.4 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DVM Pharmaceuticals Recent Developments/Updates
2.4 Virbac
2.4.1 Virbac Details
2.4.2 Virbac Major Business
2.4.3 Virbac Medications for Canine Atopic Dermatitis Product and Services
2.4.4 Virbac Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Virbac Recent Developments/Updates
2.5 Enzo Life Sciences, Inc.
2.5.1 Enzo Life Sciences, Inc. Details
2.5.2 Enzo Life Sciences, Inc. Major Business
2.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.5.4 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Enzo Life Sciences, Inc. Recent Developments/Updates
2.6 Pfizer Animal Health
2.6.1 Pfizer Animal Health Details
2.6.2 Pfizer Animal Health Major Business
2.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Product and Services
2.6.4 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Animal Health Recent Developments/Updates
2.7 Novartis Animal Health, Inc.
2.7.1 Novartis Animal Health, Inc. Details
2.7.2 Novartis Animal Health, Inc. Major Business
2.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.7.4 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Animal Health, Inc. Recent Developments/Updates
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Product and Services
2.8.4 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Company Recent Developments/Updates
2.9 Perrigo
2.9.1 Perrigo Details
2.9.2 Perrigo Major Business
2.9.3 Perrigo Medications for Canine Atopic Dermatitis Product and Services
2.9.4 Perrigo Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Perrigo Recent Developments/Updates
2.10 Merck & Company
2.10.1 Merck & Company Details
2.10.2 Merck & Company Major Business
2.10.3 Merck & Company Medications for Canine Atopic Dermatitis Product and Services
2.10.4 Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck & Company Recent Developments/Updates
2.11 Zoetis Inc.
2.11.1 Zoetis Inc. Details
2.11.2 Zoetis Inc. Major Business
2.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Product and Services
2.11.4 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zoetis Inc. Recent Developments/Updates
2.12 Toray Industries, Inc
2.12.1 Toray Industries, Inc Details
2.12.2 Toray Industries, Inc Major Business
2.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Product and Services
2.12.4 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Toray Industries, Inc Recent Developments/Updates
2.13 Bayer Animal Health
2.13.1 Bayer Animal Health Details
2.13.2 Bayer Animal Health Major Business
2.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Product and Services
2.13.4 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bayer Animal Health Recent Developments/Updates
2.14 Putney, Inc.
2.14.1 Putney, Inc. Details
2.14.2 Putney, Inc. Major Business
2.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.14.4 Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Putney, Inc. Recent Developments/Updates
2.15 Dechra
2.15.1 Dechra Details
2.15.2 Dechra Major Business
2.15.3 Dechra Medications for Canine Atopic Dermatitis Product and Services
2.15.4 Dechra Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Dechra Recent Developments/Updates
2.16 Elanco
2.16.1 Elanco Details
2.16.2 Elanco Major Business
2.16.3 Elanco Medications for Canine Atopic Dermatitis Product and Services
2.16.4 Elanco Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Elanco Recent Developments/Updates
2.17 Kindred Biosciences
2.17.1 Kindred Biosciences Details
2.17.2 Kindred Biosciences Major Business
2.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Product and Services
2.17.4 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Kindred Biosciences Recent Developments/Updates
2.18 Nippon Zenyaku Kogyo Co., Ltd.
2.18.1 Nippon Zenyaku Kogyo Co., Ltd. Details
2.18.2 Nippon Zenyaku Kogyo Co., Ltd. Major Business
2.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product and Services
2.18.4 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEDICATIONS FOR CANINE ATOPIC DERMATITIS BY MANUFACTURER
3.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer (2018-2023)
3.3 Global Medications for Canine Atopic Dermatitis Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medications for Canine Atopic Dermatitis by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medications for Canine Atopic Dermatitis Manufacturer Market Share in 2022
3.4.2 Top 6 Medications for Canine Atopic Dermatitis Manufacturer Market Share in 2022
3.5 Medications for Canine Atopic Dermatitis Market: Overall Company Footprint Analysis
3.5.1 Medications for Canine Atopic Dermatitis Market: Region Footprint
3.5.2 Medications for Canine Atopic Dermatitis Market: Company Product Type Footprint
3.5.3 Medications for Canine Atopic Dermatitis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Medications for Canine Atopic Dermatitis Market Size by Region
4.1.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2029)
4.1.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2029)
4.1.3 Global Medications for Canine Atopic Dermatitis Average Price by Region (2018-2029)
4.2 North America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.3 Europe Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.4 Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.5 South America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.6 Middle East and Africa Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
5.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2018-2029)
5.3 Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
6.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2018-2029)
6.3 Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
7.2 North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
7.3 North America Medications for Canine Atopic Dermatitis Market Size by Country
7.3.1 North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
7.3.2 North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
8.2 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
8.3 Europe Medications for Canine Atopic Dermatitis Market Size by Country
8.3.1 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
8.3.2 Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medications for Canine Atopic Dermatitis Market Size by Region
9.3.1 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
10.2 South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
10.3 South America Medications for Canine Atopic Dermatitis Market Size by Country
10.3.1 South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
10.3.2 South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medications for Canine Atopic Dermatitis Market Size by Country
11.3.1 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Medications for Canine Atopic Dermatitis Market Drivers
12.2 Medications for Canine Atopic Dermatitis Market Restraints
12.3 Medications for Canine Atopic Dermatitis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Medications for Canine Atopic Dermatitis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medications for Canine Atopic Dermatitis
13.3 Medications for Canine Atopic Dermatitis Production Process
13.4 Medications for Canine Atopic Dermatitis Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medications for Canine Atopic Dermatitis Typical Distributors
14.3 Medications for Canine Atopic Dermatitis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Medications for Canine Atopic Dermatitis
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medications for Canine Atopic Dermatitis Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 External Use
1.3.4 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Medications for Canine Atopic Dermatitis Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Veterinary Hospital
1.4.3 Veterinary Clinic
1.5 Global Medications for Canine Atopic Dermatitis Market Size & Forecast
1.5.1 Global Medications for Canine Atopic Dermatitis Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medications for Canine Atopic Dermatitis Sales Quantity (2018-2029)
1.5.3 Global Medications for Canine Atopic Dermatitis Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GlenHaven
2.1.1 GlenHaven Details
2.1.2 GlenHaven Major Business
2.1.3 GlenHaven Medications for Canine Atopic Dermatitis Product and Services
2.1.4 GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlenHaven Recent Developments/Updates
2.2 DermaPet
2.2.1 DermaPet Details
2.2.2 DermaPet Major Business
2.2.3 DermaPet Medications for Canine Atopic Dermatitis Product and Services
2.2.4 DermaPet Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 DermaPet Recent Developments/Updates
2.3 DVM Pharmaceuticals
2.3.1 DVM Pharmaceuticals Details
2.3.2 DVM Pharmaceuticals Major Business
2.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product and Services
2.3.4 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DVM Pharmaceuticals Recent Developments/Updates
2.4 Virbac
2.4.1 Virbac Details
2.4.2 Virbac Major Business
2.4.3 Virbac Medications for Canine Atopic Dermatitis Product and Services
2.4.4 Virbac Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Virbac Recent Developments/Updates
2.5 Enzo Life Sciences, Inc.
2.5.1 Enzo Life Sciences, Inc. Details
2.5.2 Enzo Life Sciences, Inc. Major Business
2.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.5.4 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Enzo Life Sciences, Inc. Recent Developments/Updates
2.6 Pfizer Animal Health
2.6.1 Pfizer Animal Health Details
2.6.2 Pfizer Animal Health Major Business
2.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Product and Services
2.6.4 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Animal Health Recent Developments/Updates
2.7 Novartis Animal Health, Inc.
2.7.1 Novartis Animal Health, Inc. Details
2.7.2 Novartis Animal Health, Inc. Major Business
2.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.7.4 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Animal Health, Inc. Recent Developments/Updates
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Product and Services
2.8.4 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Company Recent Developments/Updates
2.9 Perrigo
2.9.1 Perrigo Details
2.9.2 Perrigo Major Business
2.9.3 Perrigo Medications for Canine Atopic Dermatitis Product and Services
2.9.4 Perrigo Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Perrigo Recent Developments/Updates
2.10 Merck & Company
2.10.1 Merck & Company Details
2.10.2 Merck & Company Major Business
2.10.3 Merck & Company Medications for Canine Atopic Dermatitis Product and Services
2.10.4 Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck & Company Recent Developments/Updates
2.11 Zoetis Inc.
2.11.1 Zoetis Inc. Details
2.11.2 Zoetis Inc. Major Business
2.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Product and Services
2.11.4 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zoetis Inc. Recent Developments/Updates
2.12 Toray Industries, Inc
2.12.1 Toray Industries, Inc Details
2.12.2 Toray Industries, Inc Major Business
2.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Product and Services
2.12.4 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Toray Industries, Inc Recent Developments/Updates
2.13 Bayer Animal Health
2.13.1 Bayer Animal Health Details
2.13.2 Bayer Animal Health Major Business
2.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Product and Services
2.13.4 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bayer Animal Health Recent Developments/Updates
2.14 Putney, Inc.
2.14.1 Putney, Inc. Details
2.14.2 Putney, Inc. Major Business
2.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Product and Services
2.14.4 Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Putney, Inc. Recent Developments/Updates
2.15 Dechra
2.15.1 Dechra Details
2.15.2 Dechra Major Business
2.15.3 Dechra Medications for Canine Atopic Dermatitis Product and Services
2.15.4 Dechra Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Dechra Recent Developments/Updates
2.16 Elanco
2.16.1 Elanco Details
2.16.2 Elanco Major Business
2.16.3 Elanco Medications for Canine Atopic Dermatitis Product and Services
2.16.4 Elanco Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Elanco Recent Developments/Updates
2.17 Kindred Biosciences
2.17.1 Kindred Biosciences Details
2.17.2 Kindred Biosciences Major Business
2.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Product and Services
2.17.4 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Kindred Biosciences Recent Developments/Updates
2.18 Nippon Zenyaku Kogyo Co., Ltd.
2.18.1 Nippon Zenyaku Kogyo Co., Ltd. Details
2.18.2 Nippon Zenyaku Kogyo Co., Ltd. Major Business
2.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product and Services
2.18.4 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEDICATIONS FOR CANINE ATOPIC DERMATITIS BY MANUFACTURER
3.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer (2018-2023)
3.3 Global Medications for Canine Atopic Dermatitis Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medications for Canine Atopic Dermatitis by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medications for Canine Atopic Dermatitis Manufacturer Market Share in 2022
3.4.2 Top 6 Medications for Canine Atopic Dermatitis Manufacturer Market Share in 2022
3.5 Medications for Canine Atopic Dermatitis Market: Overall Company Footprint Analysis
3.5.1 Medications for Canine Atopic Dermatitis Market: Region Footprint
3.5.2 Medications for Canine Atopic Dermatitis Market: Company Product Type Footprint
3.5.3 Medications for Canine Atopic Dermatitis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Medications for Canine Atopic Dermatitis Market Size by Region
4.1.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2029)
4.1.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2029)
4.1.3 Global Medications for Canine Atopic Dermatitis Average Price by Region (2018-2029)
4.2 North America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.3 Europe Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.4 Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.5 South America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
4.6 Middle East and Africa Medications for Canine Atopic Dermatitis Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
5.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2018-2029)
5.3 Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
6.2 Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2018-2029)
6.3 Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
7.2 North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
7.3 North America Medications for Canine Atopic Dermatitis Market Size by Country
7.3.1 North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
7.3.2 North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
8.2 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
8.3 Europe Medications for Canine Atopic Dermatitis Market Size by Country
8.3.1 Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
8.3.2 Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medications for Canine Atopic Dermatitis Market Size by Region
9.3.1 Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
10.2 South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
10.3 South America Medications for Canine Atopic Dermatitis Market Size by Country
10.3.1 South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
10.3.2 South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medications for Canine Atopic Dermatitis Market Size by Country
11.3.1 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Medications for Canine Atopic Dermatitis Market Drivers
12.2 Medications for Canine Atopic Dermatitis Market Restraints
12.3 Medications for Canine Atopic Dermatitis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Medications for Canine Atopic Dermatitis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medications for Canine Atopic Dermatitis
13.3 Medications for Canine Atopic Dermatitis Production Process
13.4 Medications for Canine Atopic Dermatitis Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medications for Canine Atopic Dermatitis Typical Distributors
14.3 Medications for Canine Atopic Dermatitis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Medications for Canine Atopic Dermatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medications for Canine Atopic Dermatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlenHaven Basic Information, Manufacturing Base and Competitors
Table 4. GlenHaven Major Business
Table 5. GlenHaven Medications for Canine Atopic Dermatitis Product and Services
Table 6. GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlenHaven Recent Developments/Updates
Table 8. DermaPet Basic Information, Manufacturing Base and Competitors
Table 9. DermaPet Major Business
Table 10. DermaPet Medications for Canine Atopic Dermatitis Product and Services
Table 11. DermaPet Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. DermaPet Recent Developments/Updates
Table 13. DVM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. DVM Pharmaceuticals Major Business
Table 15. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product and Services
Table 16. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DVM Pharmaceuticals Recent Developments/Updates
Table 18. Virbac Basic Information, Manufacturing Base and Competitors
Table 19. Virbac Major Business
Table 20. Virbac Medications for Canine Atopic Dermatitis Product and Services
Table 21. Virbac Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Virbac Recent Developments/Updates
Table 23. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Enzo Life Sciences, Inc. Major Business
Table 25. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 26. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 28. Pfizer Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Animal Health Major Business
Table 30. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product and Services
Table 31. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Animal Health Recent Developments/Updates
Table 33. Novartis Animal Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Animal Health, Inc. Major Business
Table 35. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 36. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis Animal Health, Inc. Recent Developments/Updates
Table 38. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product and Services
Table 41. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly and Company Recent Developments/Updates
Table 43. Perrigo Basic Information, Manufacturing Base and Competitors
Table 44. Perrigo Major Business
Table 45. Perrigo Medications for Canine Atopic Dermatitis Product and Services
Table 46. Perrigo Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Perrigo Recent Developments/Updates
Table 48. Merck & Company Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Company Major Business
Table 50. Merck & Company Medications for Canine Atopic Dermatitis Product and Services
Table 51. Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck & Company Recent Developments/Updates
Table 53. Zoetis Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Zoetis Inc. Major Business
Table 55. Zoetis Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 56. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zoetis Inc. Recent Developments/Updates
Table 58. Toray Industries, Inc Basic Information, Manufacturing Base and Competitors
Table 59. Toray Industries, Inc Major Business
Table 60. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product and Services
Table 61. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Toray Industries, Inc Recent Developments/Updates
Table 63. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 64. Bayer Animal Health Major Business
Table 65. Bayer Animal Health Medications for Canine Atopic Dermatitis Product and Services
Table 66. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bayer Animal Health Recent Developments/Updates
Table 68. Putney, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Putney, Inc. Major Business
Table 70. Putney, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 71. Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Putney, Inc. Recent Developments/Updates
Table 73. Dechra Basic Information, Manufacturing Base and Competitors
Table 74. Dechra Major Business
Table 75. Dechra Medications for Canine Atopic Dermatitis Product and Services
Table 76. Dechra Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Dechra Recent Developments/Updates
Table 78. Elanco Basic Information, Manufacturing Base and Competitors
Table 79. Elanco Major Business
Table 80. Elanco Medications for Canine Atopic Dermatitis Product and Services
Table 81. Elanco Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Elanco Recent Developments/Updates
Table 83. Kindred Biosciences Basic Information, Manufacturing Base and Competitors
Table 84. Kindred Biosciences Major Business
Table 85. Kindred Biosciences Medications for Canine Atopic Dermatitis Product and Services
Table 86. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Kindred Biosciences Recent Developments/Updates
Table 88. Nippon Zenyaku Kogyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 89. Nippon Zenyaku Kogyo Co., Ltd. Major Business
Table 90. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product and Services
Table 91. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Nippon Zenyaku Kogyo Co., Ltd. Recent Developments/Updates
Table 93. Global Medications for Canine Atopic Dermatitis Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Medications for Canine Atopic Dermatitis Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Medications for Canine Atopic Dermatitis, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Medications for Canine Atopic Dermatitis Production Site of Key Manufacturer
Table 98. Medications for Canine Atopic Dermatitis Market: Company Product Type Footprint
Table 99. Medications for Canine Atopic Dermatitis Market: Company Product Application Footprint
Table 100. Medications for Canine Atopic Dermatitis New Market Entrants and Barriers to Market Entry
Table 101. Medications for Canine Atopic Dermatitis Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Medications for Canine Atopic Dermatitis Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Medications for Canine Atopic Dermatitis Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Medications for Canine Atopic Dermatitis Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Medications for Canine Atopic Dermatitis Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Medications for Canine Atopic Dermatitis Raw Material
Table 161. Key Manufacturers of Medications for Canine Atopic Dermatitis Raw Materials
Table 162. Medications for Canine Atopic Dermatitis Typical Distributors
Table 163. Medications for Canine Atopic Dermatitis Typical Customers
Table 1. Global Medications for Canine Atopic Dermatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medications for Canine Atopic Dermatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlenHaven Basic Information, Manufacturing Base and Competitors
Table 4. GlenHaven Major Business
Table 5. GlenHaven Medications for Canine Atopic Dermatitis Product and Services
Table 6. GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlenHaven Recent Developments/Updates
Table 8. DermaPet Basic Information, Manufacturing Base and Competitors
Table 9. DermaPet Major Business
Table 10. DermaPet Medications for Canine Atopic Dermatitis Product and Services
Table 11. DermaPet Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. DermaPet Recent Developments/Updates
Table 13. DVM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. DVM Pharmaceuticals Major Business
Table 15. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product and Services
Table 16. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DVM Pharmaceuticals Recent Developments/Updates
Table 18. Virbac Basic Information, Manufacturing Base and Competitors
Table 19. Virbac Major Business
Table 20. Virbac Medications for Canine Atopic Dermatitis Product and Services
Table 21. Virbac Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Virbac Recent Developments/Updates
Table 23. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Enzo Life Sciences, Inc. Major Business
Table 25. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 26. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 28. Pfizer Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Animal Health Major Business
Table 30. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product and Services
Table 31. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Animal Health Recent Developments/Updates
Table 33. Novartis Animal Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Animal Health, Inc. Major Business
Table 35. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 36. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis Animal Health, Inc. Recent Developments/Updates
Table 38. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product and Services
Table 41. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly and Company Recent Developments/Updates
Table 43. Perrigo Basic Information, Manufacturing Base and Competitors
Table 44. Perrigo Major Business
Table 45. Perrigo Medications for Canine Atopic Dermatitis Product and Services
Table 46. Perrigo Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Perrigo Recent Developments/Updates
Table 48. Merck & Company Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Company Major Business
Table 50. Merck & Company Medications for Canine Atopic Dermatitis Product and Services
Table 51. Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck & Company Recent Developments/Updates
Table 53. Zoetis Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Zoetis Inc. Major Business
Table 55. Zoetis Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 56. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zoetis Inc. Recent Developments/Updates
Table 58. Toray Industries, Inc Basic Information, Manufacturing Base and Competitors
Table 59. Toray Industries, Inc Major Business
Table 60. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product and Services
Table 61. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Toray Industries, Inc Recent Developments/Updates
Table 63. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 64. Bayer Animal Health Major Business
Table 65. Bayer Animal Health Medications for Canine Atopic Dermatitis Product and Services
Table 66. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bayer Animal Health Recent Developments/Updates
Table 68. Putney, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Putney, Inc. Major Business
Table 70. Putney, Inc. Medications for Canine Atopic Dermatitis Product and Services
Table 71. Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Putney, Inc. Recent Developments/Updates
Table 73. Dechra Basic Information, Manufacturing Base and Competitors
Table 74. Dechra Major Business
Table 75. Dechra Medications for Canine Atopic Dermatitis Product and Services
Table 76. Dechra Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Dechra Recent Developments/Updates
Table 78. Elanco Basic Information, Manufacturing Base and Competitors
Table 79. Elanco Major Business
Table 80. Elanco Medications for Canine Atopic Dermatitis Product and Services
Table 81. Elanco Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Elanco Recent Developments/Updates
Table 83. Kindred Biosciences Basic Information, Manufacturing Base and Competitors
Table 84. Kindred Biosciences Major Business
Table 85. Kindred Biosciences Medications for Canine Atopic Dermatitis Product and Services
Table 86. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Kindred Biosciences Recent Developments/Updates
Table 88. Nippon Zenyaku Kogyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 89. Nippon Zenyaku Kogyo Co., Ltd. Major Business
Table 90. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product and Services
Table 91. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Nippon Zenyaku Kogyo Co., Ltd. Recent Developments/Updates
Table 93. Global Medications for Canine Atopic Dermatitis Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Medications for Canine Atopic Dermatitis Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Medications for Canine Atopic Dermatitis, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Medications for Canine Atopic Dermatitis Production Site of Key Manufacturer
Table 98. Medications for Canine Atopic Dermatitis Market: Company Product Type Footprint
Table 99. Medications for Canine Atopic Dermatitis Market: Company Product Application Footprint
Table 100. Medications for Canine Atopic Dermatitis New Market Entrants and Barriers to Market Entry
Table 101. Medications for Canine Atopic Dermatitis Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Medications for Canine Atopic Dermatitis Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Medications for Canine Atopic Dermatitis Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Medications for Canine Atopic Dermatitis Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Medications for Canine Atopic Dermatitis Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Medications for Canine Atopic Dermatitis Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Medications for Canine Atopic Dermatitis Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Medications for Canine Atopic Dermatitis Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Medications for Canine Atopic Dermatitis Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Medications for Canine Atopic Dermatitis Raw Material
Table 161. Key Manufacturers of Medications for Canine Atopic Dermatitis Raw Materials
Table 162. Medications for Canine Atopic Dermatitis Typical Distributors
Table 163. Medications for Canine Atopic Dermatitis Typical Customers
LIST OF FIGURES
Figure 1. Medications for Canine Atopic Dermatitis Picture
Figure 2. Global Medications for Canine Atopic Dermatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. External Use Examples
Figure 6. Injection Examples
Figure 7. Global Medications for Canine Atopic Dermatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Application in 2022
Figure 9. Veterinary Hospital Examples
Figure 10. Veterinary Clinic Examples
Figure 11. Global Medications for Canine Atopic Dermatitis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Medications for Canine Atopic Dermatitis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Medications for Canine Atopic Dermatitis Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Medications for Canine Atopic Dermatitis Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Medications for Canine Atopic Dermatitis by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Medications for Canine Atopic Dermatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Medications for Canine Atopic Dermatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 53. China Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Medications for Canine Atopic Dermatitis Market Drivers
Figure 74. Medications for Canine Atopic Dermatitis Market Restraints
Figure 75. Medications for Canine Atopic Dermatitis Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Medications for Canine Atopic Dermatitis in 2022
Figure 78. Manufacturing Process Analysis of Medications for Canine Atopic Dermatitis
Figure 79. Medications for Canine Atopic Dermatitis Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Medications for Canine Atopic Dermatitis Picture
Figure 2. Global Medications for Canine Atopic Dermatitis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. External Use Examples
Figure 6. Injection Examples
Figure 7. Global Medications for Canine Atopic Dermatitis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Application in 2022
Figure 9. Veterinary Hospital Examples
Figure 10. Veterinary Clinic Examples
Figure 11. Global Medications for Canine Atopic Dermatitis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Medications for Canine Atopic Dermatitis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Medications for Canine Atopic Dermatitis Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Medications for Canine Atopic Dermatitis Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Medications for Canine Atopic Dermatitis by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Medications for Canine Atopic Dermatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Medications for Canine Atopic Dermatitis Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Medications for Canine Atopic Dermatitis Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Medications for Canine Atopic Dermatitis Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Medications for Canine Atopic Dermatitis Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 53. China Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Medications for Canine Atopic Dermatitis Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Medications for Canine Atopic Dermatitis Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Medications for Canine Atopic Dermatitis Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Medications for Canine Atopic Dermatitis Market Drivers
Figure 74. Medications for Canine Atopic Dermatitis Market Restraints
Figure 75. Medications for Canine Atopic Dermatitis Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Medications for Canine Atopic Dermatitis in 2022
Figure 78. Manufacturing Process Analysis of Medications for Canine Atopic Dermatitis
Figure 79. Medications for Canine Atopic Dermatitis Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
